Genrix (shanghai) Biopharmaceutical Co., Ltd.

This study is testing whether an experimental injection called GR1802, when added to a patient's usual allergy medications, can better control seasonal allergy symptoms like sneezing, runny nose, and itchy eyes. It will involve 144 adults with a history of poorly controlled seaso…

This is the first human study of an experimental injection called GR2301. Researchers will give single doses to 36 healthy adults in China to check for side effects and see how the body processes it. The study will follow participants for about 4 months to monitor their health an…